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Summary
Purpose:  Pseudomonas  aeruginosa  is  a  signiﬁcant  cause  of  burn  wound  infections
and,  skin  and  soft  tissue  infections.  The  antiseptic  management  is  an  integral  part
of  the  management  of  wound  infections  and  is  essential  to  control  wound  infection.
Although  commonly  used,  concerns  have  been  raised.
Results:  Available  experimental  data  suggest  that  many  commonly  used  antiseptic
agents  may  be  toxic  to  the  cells  involved  in  wound  healing  process  and  may  affect
the  process  of  normal  tissue  repair.  In  view  of  this,  the  present  review  summarized
the  various  organic  acids  commonly  used  as  a  substitute  for  antiseptics  to  control
pseudomonal  wound  infections  with  special  reference  to  acetic  acid  and  their  role
in  the  process  of  wound  healing.
Conclusion:  Acetic  acid  is  to  be  kept  in  mind  as  one  of  the  alternatives  when  infection
is  caused  by  multiple  antibiotic  resistant  strains  of  P.  aeruginosa.  At  a  time  when
bacterial  resistance  to  antibiotics  is  a matter  of  increasing  concern,  the  value  of
topical  agents  such  as  acetic  acid  should  not  be  forgotten.
©  2013  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.Contents
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seudomonas  aeruginosa  is  a  classic  opportunistic
athogen with  innate  resistance  to  many  antibi-
tics and  disinfectants  [1].  It  is  resistant  to  some
ommon  antiseptics  and  disinfectants  such  as  qua-
ernary ammonium  compounds  (e.g.,  cetrimide  and
enzalkonium  chloride),  chloroxylenol  and  hex-
chlorophane  [2,3].  Its  isolation  has  been  reported
rom  povidone-iodine,  chlorhexidine,  dettol  and
avlon solutions  used  in  hospitals  [4—8]. In  recent
ears, P.  aeruginosa  has  acquired  signiﬁcance  as  an
mportant cause  of  nosocomial  infections  because
f its  ability  to  survive  in  the  hospital  environment
nd because  of  its  ability  to  develop  resistance  to
ntimicrobial  agents.  It  is  ubiquitous  in  the  hospital
nvironment  and  is  the  most  frequently  isolated
onfermentative  bacillus  from  various  clinical
pecimens. It  can  infect  almost  any  external  site  or
rgan in  the  body.  It  is a  signiﬁcant  cause  of  burn
ound infections,  and  skin  and  soft  tissue  infec-
ions.  Approximately,  one  third  of  burn  wounds
re caused  by  P.  aeruginosa. It  is  an  important
ause of  nosocomial  infections  and  is  associated
ith high  morbidity,  increased  stay  in  the  hospital
nd increase  the  cost  of  treatment  because  of  its
esistance  to  a  variety  of  antipseudomonal  agents
ommonly  available.  In  recent  years,  an  increased
requency of  strains  resistant  to  several  antimicro-
ial agents  have  been  reported  [9—11].  In  spite  of
ontinuing  introduction  of  potent  antipseudomonal
gents, it  is  the  most  difﬁcult  nosocomial  pathogen
o be  eliminated  from  infection  site.  Growing
esistance to  antimicrobial  agents  seriously  ham-
ers the  therapy  of  pseudomonal  infections.  The
ncidence  of  such  multiple  drug  resistant  isolates
emains  very  high  in  burn  units.  P.  aeruginosa  is  the
ost commonly  encountered  and  most  difﬁcult  to
radicate,  needs  special  attention,  if uncontrolled,
ecomes life  threatening.  There  is  a substantial
vidence that  excessive  use  of  antibiotics  promotes
he selection,  propagation  and  maintenance  of
ntibiotic  resistant  microbes,  especially  in  the
ospital  environment.  In  the  recent  times,  the
dvent  of  new  antimicrobial  agents  has  helped
o decrease  the  seriousness  of  many  types  of
i
t
i
pnfections  but  in  case  of  nosocomial  infections
aused by  P.  aeruginosa, the  results  have  been
ess satisfactory  and  still  the  nosocomial  infec-
ions  caused  by  P.  aeruginosa  present  a  serious
roblem. The  burn  wound  infections  and,  skin  and
oft infections  caused  by  P.  aeruginosa  are  very
ifﬁcult to  treat,  in  spite  of  availability  of  newer
ntibiotics with  broad  spectrum  of  activity.  Thus,  P.
eruginosa continues  to  create  a threat  to  patient
are [1—3,7,8,11].
ocal wound care agents (antiseptics)
he  optimal  topical  treatment  is  a balance  between
icrobicidal  activity  and  tolerability.  Generally,
ighly reactive  antiseptics  are  estimated  as  too
oxic (though  there  are  reports  on  the  usability  of
gents like  hypochlorous  acid).  Modern  antiseptics
re less  reactive  and  need  a  little  longer  killing
imes against  pathogens  but  are  still  efﬁcient.
To the  clinician  it  is  obvious  that  reducing  the
umber of  bacteria  in  wounds  is  ultimately  aimed
t accelerating  wound  healing.  The  antiseptic  man-
gement has  a  dichotomous  history  anchored  in  tra-
ition and  science.  It  is  an  integral  part  of the  man-
gement  of  acute  as  well  as  chronic  wounds  [12,13].
he ideal  topical  therapy  is  aimed  at  reduction
f bacterial  contamination  and  removal  of  soluble
ebris without  adversely  affecting  cellular  activi-
ies vital  to  wound  healing  process.  Although  sev-
ral studies  support  the  value  of  topical  antimicro-
ial agents,  many  commonly  used  antiseptic  agents
re not  approved  for  use  in  wound  infections.  The
afety and  efﬁcacy  of  many  antiseptics  as  topical
gents  for  local  wound  care  is  a questionable  issue.
 number  of  experimental  studies  both  in  vitro
nd in  animal  wounds  suggest  that  many  antisep-
ic agents  including  iodine,  chlorhexidine,  hydrogen
eroxide,  alcohol,  silver  sulfadiazine,  mefenide
cetate, sodium  nitrate,  sodium  hypochlorite,  etc.
ay be  toxic  to  the  cells  involved  in  wound  heal-ng process.  Available  experimental  data  suggest
hat the  antiseptics  such  as  hydrogen  peroxide  and
odine are  not  only  toxic  to  ﬁbroblasts  but  also
otentially retard  the  contribution  of  ﬁbroblasts
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in  healing  process  [14,15].  Repeated  and  excessive
treatment  of  wounds  with  antiseptic  agents,  except
for short-time  application  to  attack  the  causative
pathogens and  to  control  the  infection,  may  have
negative  outcomes  or  promote  a  microenvironment
similar to  those  found  in  chronic  wounds  [15].
Silver sulfadiazine  has  a  broad  spectrum  of
antibacterial, antifungal  and  antiviral  activity.  It  is
the most  commonly  used  antiseptic  agent  in  burn
wound  management  but  it  is  toxic  to  ﬁbroblasts
in culture  [16].  Also,  it  requires  frequent  dressing
changes, delays  re-epithelization  and  stains  tissue.
It may  also  cause  allergic  reaction  and  transient
leucopenia [17].
Mefenide  acetate  (sulfamylon)  has  a broad
antibacterial spectrum  and  has  ability  to  penetrate
eschar,  its  disadvantages  include  occasional  pain  on
application  and  inhibition  of  epithelization  [18,19].
Silver nitrate  also  has  a  broad  antibacterial  spec-
trum but  its  application  to  wound  can  slow  down  the
process of  epithelization  [20].
Betadine  (povidone-iodine)  is  most  commonly
used antiseptic  agent.  It  covers  a  broad  antibacte-
rial and  antifungal  spectrum  but  in  most  instances,
it does  not  effectively  promote  good  wound  heal-
ing. Most  studies  show  that  it  impairs  wound  healing
and reduces  wound  strength  [20].  Cooper  and  Laer
observed  that  betadine  solution  tested  at  multiple
dilutions was  found  to  be  most  toxic  of  all  agents
tested on  ﬁbroblasts  [21]  and  has  deleterious  effect
on wound  epithelization  when  used  in  non-diluted
concentrations  [22].
Dakin’s  solution  containing  hypochlorite  (dilute
bleach)  has  a  broad  antibacterial  activity  but  is
toxic to  ﬁbroblasts  and  it  has  been  found  that
wound treated  with  Dakin’s  solution  were  signif-
icantly slower  to  epithelize  and  neovascularize
[23—25].  It  also  retards  collagen  synthesis  and
delays  epithelization,  and  also  inhibits  migration  of
neutrophils  in  a  wound  bed,  thus  undermining  the
body’s natural  defense  system  [22].  They  are  toxic
to tissues  because  they  oxidize  tissue  enzymes  [26].
Antiseptic agents  such  as  hydrogen  peroxide,
iodine and  alcohol  and  others  are  also  cytotoxic
and retard  wound  healing  process  [27,28]. Hydro-
gen peroxide  disrupts  new  capillaries  in  granulation
tissue and  also  it  oxidizes  wound  debris,  and  it  is
toxic to  ﬁbroblasts  [22].
Dilute  acetic  acid  though  successfully  used  by
many workers  for  the  treatment  of  wound  infec-
tions caused  by  P.  aeruginosa, Lineaweaver  et  al.
showed that  a  0.25%  acetic  acid  solution  killed
100% of  exposed  ﬁbroblasts  in  an  in  vitro  model  so
that impaired  wound  healing  would  be  expected
at any  clinically  effective  concentration.  Acetic
acid has  also  been  shown  to  slow  down  the  wound
i
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pithelization  and  to  limit  polymorphonuclear  —
eutrophil  function  [29].
As reported  by  various  workers,  these  agents  are
ytotoxic,  retard  healing  and  can  do  more  harm
han good  when  they  are  not  used  in  a  proper
oncentration.  They  can  interfere  with  the  normal
ealing  process,  are  toxic  to  ﬁbroblasts  and  may
ermit  more  virulent  microbes  to  dominate  [30].
he result  of  these  observations  has  been  that  the
se of  antiseptics  is  now  often  criticized  practice;
owever use  of antiseptics  at  a concentration  that
s effective  and  well  tolerated,  and  discontinua-
ion of  application  as  soon  as  the  clinical  signs  of
nfection  disappear,  can  be  practiced.
cetic acid treatment
 variety  of  chemical  agents  are  available,  which
re nontoxic,  inexpensive  and  highly  effective
gainst nosocomial  strains  of  P. aeruginosa. It  has
een reported  that  in  some  cases  of  local  appli-
ations, chemical  agents  have  advantages  over
ntibiotics,  especially  in  controlling  hospital  strains
f P.  aeruginosa, which  are  resistant  to  multi-
le antipseudomonal  agents  commonly  used  in
he treatment  of  pseudomonal  wound  infections.
hese agents  can  be  used  locally  in the  treatment
f pseudomonal  wound  infections  and  the  use  of
ntibiotics  can  be  avoided  to  some  extent.  Krasil-
ikov et  al.  studied  susceptibility  of  P.  aeruginosa
gainst antibiotics  and  antiseptic  preparations  cur-
ently used  in  medical  practice  and  found  that  in
ome cases  of  local  application  antiseptic  prepara-
ions have  advantages  over  antibiotics,  especially  in
ontrolling hospital  strains  of  microorganisms  [31].
he topical  use  of  various  organic  acids  such  as  boric
cid, ascorbic  acid,  citric  acid,  salicyclic  acid  and
cetic acid  for  elimination  of  P.  aeruginosa  from
kin and  soft  tissue  infections  and  from  burn  infec-
ions has  been  reported  by  various  workers.
Kujath  and  Hugelschaffer  in  1987  used  3%  boric
cid to  treat  local  pseudomonas  wound  infections  in
0 patients  in  which  antibiotics  had  been  found  to
ield little  lasting  success.  They  applied  boric  acid
ocally and  achieved  a good  success  in  less  than  six
ays on  an  average  without  any  toxic  side  effects
32]. Adarchenko  et  al.  studied  the  effect  of  vari-
us antiseptics  on  P.  aeruginosa  and  found  that  the
ctivity of  boric  acid  was  higher  against  the  clinical
solates  of  P.  aeruginosa  [33].
Mujumdar in  1993  reported  use  of  ascorbic  acid
n 35  cases  with  second  degree  burn  injury  involv-
ng 20—40%  of  body  surface  area  infected  with  P.
eruginosa. He  used  2%  ascorbic  acid  to  wash  wound
horoughly  and  to  create  acidic  medium  in  tropical
limate  where  warm  weather  and  alkalinity  of  the
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icetic  acid  treatment  of  pseudomonal  wound  infec
edium  renders  0.1%  silver  sulfadiazine  less  effec-
ive. This  treatment  modality  showed  a  dramatic
eduction (88%)  in  pseudomonas  infection  from  94%
pre-treatment)  to  6%  (post-treatment)  [34].
In our  earlier  studies  on  pseudomonal  wound
nfections, we  have  used  2—3%  citric  acid  for  the
uccessful treatment  of  burn  wound  infections,
nd skin  and  soft  tissue  infections  caused  by  P.
eruginosa  including  multiple  drug  resistant  strains
ot responding  to  conventional  therapies,  which
ncluded the  oral  or  injectable  antibiotics  and  local
ound care  by  using  hydrogen  peroxide  and  beta-
ine.  Application  of  citric  acid  quickly  eliminated
. aeruginosa  from  infection  site.  Citric  acid  was
ound  to  be  simple,  reliable,  nontoxic,  effective
nd economical  approach  in  the  management  of
uperﬁcial  infections  caused  by  multiple  antibiotic
esistant  strains  of  P.  aeruginosa  [35,36].  The  sali-
yclic acid  has  also  been  reported  effective  against
. aeruginosa  in  a  concentration  of  0.5—2%  and  in
 concentration  of  0.5%  has  been  found  to  be  safe
nd inexpensive  topical  agent  suitable  for  thermal
urns,  which  are  not  heavily  contaminated  [37].
The use  of  acetic  acid  has  been  reported  from
ime to  time  as  a  topical  agent  for  the  treatment
f pseudomonal  infections  of  burns  and,  skin  and
oft tissue  infections.  Dilute  acetic  acid  is  used
or the  treatment  of  chronic  wounds.  It  is  effec-
ive against  Gram-negative  bacteria,  especially
gainst P.  aeruginosa.  Clinical  antibacterial  efﬁcacy
equires a  concentration  of  a  0.5%  at  least.  Acetic
cid has  been  successfully  used  by  many  workers
or the  treatment  of  wound  infections  caused  by
. aeruginosa. Though,  the  results  of  in  vitro  stud-
es indicate  that  acetic  acid  is  toxic  to  ﬁbroblasts,
hese results  are  not  considered  as  decisive.  As
cetic acid  is well  tolerated  in  vivo  and  gives  better
esults  in  the  treatment  of  wound  infections  caused
y P.  aeruginosa, its  use  has  been  reported  from
ime to  time  as  an  effective  topical  agent.
n vitro studies on effect of acetic acid
he  in  vitro  effect  of  acetic  acid  was  studied
y various  workers  using  different  concentrations
f acetic  acid  against  the  clinical  isolates  of  P.
eruginosa  isolated  from  patients  suffering  from
seudomonal  wound  infections.  Husain  et  al.  were
rst to  analyze  the  sensitivity  of  P.  aeruginosa, iso-
ated from  burn  wound  swabs,  to  various  topical
gents and  found  that  acetic  acid  was  one  of  the
gents  active  against  P.  aeruginosa  in  in  vitro  stud-
es [38].  Sloss  et  al.  studied  in  vitro  activity  of
cetic acid  in  a  concentration  of  0.1—10%,  either
pplied to  the  surface  of  agar  plates  or  placed  in
ells cut  into  the  agar.  Plates  were  incubated  at
a
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7 ◦C  for  18  h  and  observed  for  zones  of  inhibition
fter incubation.  They  found  that  acetic  acid  at  a
oncentration  of  2%  was  highly  effective  against  P.
eruginosa  [39].
In  our  earlier  studies  on  determination  of  the
inimum inhibitory  concentration  (MIC)  of  acetic
cid, each  isolate  of  P.  aeruginosa  was  inoc-
lated into  peptone  water  and  incubated  for
 h.  After  incubation,  turbidity  of  peptone  water
as matched  with  McFarland  standard  No.1  and
djusted  accordingly.  A  set  of  ﬁve  test  tubes  was
aken to  study  the  effect  of  ﬁve  different  concen-
rations of  acetic  acid  (1—5%).  A  100  L  of  peptone
ater culture  was  taken  in  ﬁve  tubes  and  100  L of
ve different  concentrations  were  added  to  ﬁve  dif-
erent tubes.  After  proper  mixing,  subcultures  were
ade on  pseudomonas  isolation  agar  (PIA)  after  5,
0 and  15  min  of  exposure.  The  PIA  plates  were
ncubated at  37 ◦C  and  after  overnight  incubation
lates were  observed  for  growth.  In  our  studies,  a
oncentration  of  3%  acetic  acid  was  found  to  have
acteriostatic  activity  against  P.  aeruginosa  includ-
ng multiple  antibiotic  resistant  strains  [40,41].
In vitro  susceptibility  to  acetic  acid  was  also
tudied by  Juma  et  al.  by  using  different  concentra-
ions of  acetic  acid  (0.5—2%)  and  reported  highest
one of  inhibition  (18  or  more)  at  a concentration
f 2%  [37].
ethods of application
loss  et  al.  applied  sterile  gauze  swabs  soaked  in
cetic acid  (in  dilutions  of  1—5%)  to  the  ulcers
nd to  smaller  burn  wounds  for  15  min  twice  daily
or 1—2  weeks.  In addition  bath  water  contain-
ng approximately  0.5%  acetic  acid  was  used  to
mmerse  each  of  4  patients  with  purulent  burn
ounds for  22—45  min  each  day;  during  this  time
ounds were  debrided  [39]. In  our  studies,  based  on
IC value  of  3%  in  in  vitro  studies,  3%  acetic  acid  was
repared  by  adding  3  ml  of  acetic  acid  to  97  ml  of
terile distilled  water  and  the  following  steps  were
sed for  its  application:
.  Irrigation  and  washing  of  wound  with  normal
saline.
. Placing  of  a sterile  gauze  soaked  in  acetic  acid
over the  wound.
. Dressing  of  the  wound.
In  this  way,  acetic  acid  was  applied  once  daily  or
n alternate  days  based  on  the  severity  of  wound
nfection  (daily  once  in  a  severely  infected  wound
nd on  alternate  days  in  a  less  severe  wounds)  until
he wound  healed  completely  [40,41].
In another  study,  a dilute  vinegar  and  water  solu-
ion were  found  to  be  superb  means  of  eradicating
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local  P.  aeruginosa  wound  infections.  It  was  used
as an  irrigating  solution  or  a  foot  soak  in  infected
necrotic wounds,  particularly  if  associated  with  P.
aeruginosa or  anaerobic  ﬂora.  In  this  study,  a  com-
monly used  dilution  was  15  ml  of  5%  acetic  acid  per
200 ml  of water  or  saline  for  foot  soak  for  10—15  min
[42].
Studies  on  human  pseudomonal  wounds
Philips  et  al.  was  ﬁrst  to  report  use  of  acetic
acid as  a  topical  agent  for  the  treatment  of
superﬁcial wounds  infected  by  P.  aeruginosa  [43].
Sloss et  al.  reported  topical  use  of  acetic  acid  at
concentrations  between  0.5%  and  5%  to  eliminate
P. aeruginosa  from  the  burn  wounds  and  soft  tissue
wounds.  They  found  that  all  strains  of  P.  aeruginosa
exhibited a  minimum  inhibitory  concentration
of 2%  in  vitro.  They  successfully  eliminated  P.
aeruginosa from  wounds  of  14  of  the  16  patients
within two  weeks  of  treatment.  Acetic  acid  was
shown to  be  an  inexpensive  and  efﬁcient  agent  for
the elimination  of  P.  aeruginosa  from  burn  and  soft
tissue wounds  [39].
In our  earlier  studies,  use  of  3—5%  acetic
acid showed  encouraging  clinical  changes  in  pseu-
domonal  wound  infections.  Application  of  3—5%  of
acetic acid  to  wounds,  which  were  not  responding
to conventional  therapies,  which  included  the  oral
or injectable  antibiotics  and  local  wound  care  by
using hydrogen  peroxide  and  betadine,  successfully
controlled infections  by  P.  aeruginosa  thereby  elim-
inating them  from  local  site  of  wound  and  caused
successful healing  in  5—12  applications  without  any
adverse effects  [40,41].
Al-Ibran  and  Khan  in  2010  studied  the  effect  of
1% acetic  acid  in  burn  wounds  in  eradication  of  P.
aeruginosa  infection  and  found  that  application  of
acetic acid  for  10—14  days  cleared  P.  aeruginosa  in
90% of  cases  [44].
Conclusion
Acetic  acid  was  found  to  have  bacteriostatic  activ-
ity against  P.  aeruginosa, including  multiple  antibi-
otic resistant  strains  of  P.  aeruginosa. Acetic  acid
in a  concentration  of  0.5—5%  was  found  efﬁcient  in
elimination  of  P.  aeruginosa  from  superﬁcial  infec-
tion site.  Such  local  antiseptic  preparations  have
advantages  over  antibiotics  in  that  their  use  does
not encourage  evolution  of  multiple  drug  resistant
strains of  microorganisms  in  hospital  environment.
It is  to  be  kept  in  mind  as  one  of  the  alternatives
when infection  is caused  by  multiple  antibiotic
resistant strains  of  P.  aeruginosa, in  which  thereB.S.  Nagoba  et  al.
s  shortage  of  therapeutic  options.  At  a  time  when
acterial  resistance  to  antibiotics  is  a matter  of
ncreasing  concern,  the  value  of  topical  agents  such
s acetic  acid  should  not  be  forgotten.
Further clinical  trials  using  suitable  control
roups treated  with  antiseptics  or  antibiotics  for
omparison  will  help  in  achieving  more  useful
nd concrete  conclusions  regarding  the  efﬁcacy  of
cetic acid  in  controlling  wound  infections  caused
y P.  aeruginosa  including  multiple  antibiotic  resis-
ant strains.  Hence,  such  clinical  trials  involving
uitable control  groups  are  recommended.
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